Under the anti-inflammatory properties, in the TNBS-induced colitis model, placenta tissue-derived MSC-EVs significantly reduced levels of IL-6 and TNF-α, contributing to the amelioration of disease severity and improved histological architecture[32]. This evidence concerns the gene IL6 and colitis.